Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates
Muhammad Kalim,1 Jie Chen,1 Shenghao Wang,1 Caiyao Lin,1 Saif Ullah,1 Keying Liang,1 Qian Ding,1 Shuqing Chen,2 Jinbiao Zhan1 1Department of Biochemistry and Genetics, School of Medicine, 2Department of Pharmaceutical Analysis, College of Pharmaceutical Science, Zhejiang University, Hangzhou, People...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2017-08-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_a5e43fcbcd9945d39df6eb7e6e8a2891 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Kalim M |e author |
| 700 | 1 | 0 | |a Chen J |e author |
| 700 | 1 | 0 | |a Wang S |e author |
| 700 | 1 | 0 | |a Lin C |e author |
| 700 | 1 | 0 | |a Ullah S |e author |
| 700 | 1 | 0 | |a Liang K |e author |
| 700 | 1 | 0 | |a Ding Q |e author |
| 700 | 1 | 0 | |a Chen S |e author |
| 700 | 1 | 0 | |a Zhan JB |e author |
| 245 | 0 | 0 | |a Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates |
| 260 | |b Dove Medical Press, |c 2017-08-01T00:00:00Z. | ||
| 500 | |a 1177-8881 | ||
| 520 | |a Muhammad Kalim,1 Jie Chen,1 Shenghao Wang,1 Caiyao Lin,1 Saif Ullah,1 Keying Liang,1 Qian Ding,1 Shuqing Chen,2 Jinbiao Zhan1 1Department of Biochemistry and Genetics, School of Medicine, 2Department of Pharmaceutical Analysis, College of Pharmaceutical Science, Zhejiang University, Hangzhou, People’s Republic of China Abstract: Antibody–drug conjugate (ADC) is a milestone in targeted cancer therapy that comprises of monoclonal antibodies chemically linked to cytotoxic drugs. Internalization of ADC takes place via clathrin-mediated endocytosis, caveolae-mediated endocytosis, and pinocytosis. Conjugation strategies, endocytosis and intracellular trafficking optimization, linkers, and drugs chemistry present a great challenge for researchers to eradicate tumor cells successfully. This inventiveness of endocytosis and intracellular trafficking has given consi­derable momentum recently to develop specific antibodies and ADCs to treat cancer cells. It is significantly advantageous to emphasize the endocytosis and intracellular trafficking pathways efficiently and to design potent engineered conjugates and biological entities to boost efficient therapies enormously for cancer treatment. Current studies illustrate endocytosis and intracellular trafficking of ADC, protein, and linker strategies in unloading and also concisely evaluate practically applicable ADCs. Keywords: antibody–drug conjugate, antibody, endocytosis, intracellular trafficking, clathrin | ||
| 546 | |a EN | ||
| 690 | |a Antibody-drug conjugate | ||
| 690 | |a Antibody | ||
| 690 | |a Endocytosis | ||
| 690 | |a Intracellular trafficking | ||
| 690 | |a Clathrin | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Drug Design, Development and Therapy, Vol Volume 11, Pp 2265-2276 (2017) | |
| 787 | 0 | |n https://www.dovepress.com/intracellular-trafficking-of-new-anticancer-therapeutics-antibody-drug-peer-reviewed-article-DDDT | |
| 787 | 0 | |n https://doaj.org/toc/1177-8881 | |
| 856 | 4 | 1 | |u https://doaj.org/article/a5e43fcbcd9945d39df6eb7e6e8a2891 |z Connect to this object online. |